Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Fallopian Tube Cancer Stage III”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Large-scale testing (Phase 3)Study completedNCT02903004
What this trial is testing

Trial on Trabectedin (ET-743) vs Clinician's Choice Chemotherapy in Recurrent Ovarian, Primary Peritoneal or Fallopian Tube Cancers of BRCA Mutated or BRCAness Phenotype Patients

Who this might be right for
Ovarian Neoplasms
Fondazione Policlinico Universitario Agostino Gemelli IRCCS 242
Large-scale testing (Phase 3)Not Yet RecruitingNCT07545460
What this trial is testing

A Study Comparing BL-M07D1 With Physician's Choice of Chemotherapy in Patients With HER2-Expressing Platinum-Resistant Recurrent Epithelial Ovarian Cancer, Fallopian Tube Cancer, and Primary Peritoneal Cancer

Who this might be right for
Epithelial Ovarian CancerFallopian Tube CancerPrimary Peritoneal Cancer
Sichuan Baili Pharmaceutical Co., Ltd. 404
Early research (Phase 1)Study completedNCT00060359
What this trial is testing

Polyglutamate Paclitaxel and Carboplatin in Treating Patients With Ovarian Epithelial, Peritoneal, or Fallopian Tube Cancer

Who this might be right for
Fallopian Tube CarcinomaMalignant Ovarian Mixed Epithelial TumorOvarian Brenner Tumor+8 more
Gynecologic Oncology Group 32
Not applicableStudy completedNCT00293293
What this trial is testing

Outcomes in Ovarian Cancer and Fallopian Tube Cancer Patients Using Complementary Alternative Medicine

Who this might be right for
Ovarian CancerPeritoneal Primary CancerFallopian Tube Cancer
Masonic Cancer Center, University of Minnesota 43
Not applicableStudy completedNCT01080521
What this trial is testing

Changes in Brain Function in Patients With Stage I, Stage II, Stage III, or Stage IV Ovarian, Primary Peritoneal, or Fallopian Tube Cancer Who Are Receiving Chemotherapy

Who this might be right for
Cognitive Side Effects of Cancer TherapyMalignant Ovarian Epithelial TumorOvarian Brenner Tumor+51 more
Gynecologic Oncology Group 247
Large-scale testing (Phase 3)Looking for participantsNCT05737303
What this trial is testing

Nab-paclitaxel Versus Sb-taxanes As First-Line Treatment in Advanced Ovarian Cancer

Who this might be right for
Epithelial Ovarian Carcinoma Stage IIIEpithelial Ovarian Carcinoma Stage IVFallopian Tube Carcinoma Stage III+3 more
Women's Hospital School Of Medicine Zhejiang University 538
Early research (Phase 1)Study completedNCT00085358
What this trial is testing

Carboplatin and Paclitaxel With or Without Bevacizumab Compared to Docetaxel, Carboplatin, and Paclitaxel in Treating Patients With Stage II, Stage III, or Stage IV Ovarian Epithelial, Fallopian Tube, or Primary Peritoneal Cavity Carcinoma (Cancer)

Who this might be right for
Brenner TumorFallopian Tube CancerOvarian Carcinosarcoma+10 more
National Cancer Institute (NCI) 40
Testing effectiveness (Phase 2)UnknownNCT00003560
What this trial is testing

Docetaxel Plus Carboplatin in Treating Patients With Stage III or Stage IV Ovarian, Fallopian Tube, or Primary Peritoneal Cancer

Who this might be right for
Endometrial CancerFallopian Tube CancerOvarian Cancer+1 more
Herbert Irving Comprehensive Cancer Center 40
Large-scale testing (Phase 3)Study completedNCT00028743
What this trial is testing

Combination Chemotherapy Regimens in Ovarian Epithelial Cancer, Primary Peritoneal Cancer, or Fallopian Tube Cancer

Who this might be right for
Fallopian Tube CancerOvarian CancerPeritoneal Cavity Cancer
NCIC Clinical Trials Group 819
Early research (Phase 1)Looking for participantsNCT07665515
What this trial is testing

Study of CryptiVax-1001 in Maintenance Setting for Advanced Serous Ovarian, Fallopian Tube, or Primary Peritoneal Cancer

Who this might be right for
Ovarian CancerHGSOCHGS Ovarian, Fallopian Tube or Primary Peritoneal Cancer
Epitopea Ltd 50
Testing effectiveness (Phase 2)UnknownNCT03462212
What this trial is testing

Carboplatin-Paclitaxel-Bevacizumab vs Carbo-Pacli-Beva-Rucaparib vs Carbo-Pacli-Ruca, Selected According to HRD Status, in Patients With Advanced Ovarian, Primary Peritoneal and Fallopian Tube Cancer, Preceded by a Phase I Dose Escalation Study on Ruca-Beva Combination

Who this might be right for
Advanced (Stage IIIB-C-IV) Ovarian, Primary Peritoneal and Fallopian Tube Cancer
Fondazione Policlinico Universitario Agostino Gemelli IRCCS 290
Early research (Phase 1)Active Not RecruitingNCT05691504
What this trial is testing

Testing the Combination of APG-1252 (Pelcitoclax) and Cobimetinib in Recurrent Ovarian and Endometrial Cancers

Who this might be right for
Advanced Endometrial CarcinomaMetastatic Endometrial CarcinomaMetastatic Fallopian Tube Carcinoma+8 more
National Cancer Institute (NCI) 42
Testing effectiveness (Phase 2)Study completedNCT00031954
What this trial is testing

Combination Chemotherapy in Treating Patients With Ovarian Epithelial, Fallopian Tube, or Peritoneal Cancer

Who this might be right for
Fallopian Tube CancerOvarian CancerPrimary Peritoneal Cavity Cancer
AGO Study Group 105
Large-scale testing (Phase 3)Study completedNCT00263822
What this trial is testing

Erlotinib or Observation in Treating Patients Who Have Undergone First-Line Chemotherapy for Ovarian Cancer, Peritoneal Cancer, or Fallopian Tube Cancer

Who this might be right for
Fallopian Tube CancerOvarian CancerPrimary Peritoneal Cavity Cancer
European Organisation for Research and Treatment of Cancer - EORTC 835
Very early researchStudy completedNCT01626014
What this trial is testing

Interactive Educational Website for Women With Ovarian Cancer & Caregivers

Who this might be right for
Stage III Ovarian CancerStage IV Ovarian CancerRecurrent Ovarian Cancer+1 more
University of Minnesota 53
Large-scale testing (Phase 3)Study completedNCT03635489
What this trial is testing

The Efficacy and Safety of Bevacizumab in Chinese Women With Newly Diagnosed, Previously Untreated Stage III or Stage IV Epithelial Ovarian, Fallopian Tube, or Primary Peritoneal Cancer

Who this might be right for
Ovarian CancerFallopian Tube CancerPrimary Peritoneal Cancer
Hoffmann-La Roche 100
Testing effectiveness (Phase 2)Study completedNCT03188432
What this trial is testing

Hyperthermic Intraperitoneal Chemotherapy Trial Comparing Quality of Life in Patients With Stage IIIC-IV Ovarian, Fallopian Tube, or Primary Peritoneal Cancer

Who this might be right for
Stage IIIC Fallopian Tube CancerStage IIIC Ovarian CancerStage IIIC Primary Peritoneal Cancer+3 more
Wake Forest University Health Sciences 50
Testing effectiveness (Phase 2)Active Not RecruitingNCT02726997
What this trial is testing

Matched Paired Pharmacodynamics and Feasibility Study of Durvalumab in Combination With Chemotherapy in Frontline Ovarian Cancer (N-Dur)

Who this might be right for
Stage III Fallopian Tube Cancer AJCC v7Stage III Ovarian Cancer AJCC v6 and v7Stage III Primary Peritoneal Cancer AJCC v7+12 more
M.D. Anderson Cancer Center 18
Large-scale testing (Phase 3)UnknownNCT03705156
What this trial is testing

Clinical Trial Evaluating the Efficacy and Safety of ZL-2306 (Niraparib) in Ovarian Cancer Patient

Who this might be right for
Platinum-sensitive Relapsed Ovarian Cancer
Zai Lab (Shanghai) Co., Ltd. 265
Large-scale testing (Phase 3)UnknownNCT01611766
What this trial is testing

Surgery or Chemotherapy in Recurrent Ovarian Cancer (SOC 1 Trial)?

Who this might be right for
Ovarian Epithelial Cancer RecurrentFallopian Tube CarcinomaPrimary Peritoneal Carcinoma
Shanghai Gynecologic Oncology Group 356
Next Page